Integrated Smartphone Technology to Alleviate Malignant Pain (I-STAMP) Testing
Starting soon · Not applicable
Conditions studied: Advanced Cancer, Pain
In brief
The purpose of the study is to evaluate if the smartphone app, I-STAMP (Integrated Smartphone Technology to Alleviate Malignant Pain), helps participants with cancer pain manage symptoms and keep track of medications.
Key facts
- Study ID
- NCT06117709
- Run by
- Dana-Farber Cancer Institute
- People needed
- 73
- Starts
- 2026-08-01
- Expected to finish
- 2026-11-30
- Last updated by the study team
- 2026-07-16
Who can join
Age: 21 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Dana Farber Cancer Institute — Boston, Massachusetts, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.